Cardiology
Partner With Us
Advertisement
Conexiant chevron_right Cardiology chevron_right Evolocumab Reduced CV Events in Diabetes
From the Journals Clinical Guidelines Conference News American College of Cardiology's 75th Annual Scientific Session & Expo

Evolocumab Reduced CV Events in Diabetes

Subgroup analysis of the VESALIUS-CV trial supports earlier intensive lipid lowering

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.